Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.05 USD
Change Today -0.03 / -0.42%
Volume 24.1K
GLYC On Other Exchanges
As of 5:20 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rachel K. King

Co-Founder, Chief Executive Officer, President and Director,GlycoMimetics, Inc.
AgeTotal Calculated CompensationThis person is connected to 104 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mrs. Rachel K. King co-founded Glycomimetics, Inc. in 2003 and has been its Chief Executive Officer Since 2003 and has been its President since 2003. Mrs. King served as an Executive in Residence at New Enterprise Associates (NEA), a major venture capital firm with investments in biotechnology and at Novartis Venture Fund. She served as a Senior Vice President of Novartis Corporation. She served as an executive with Genetic Therapy, Inc. for ten years right from its ...

Read Full Background

Corporate Headquarters*

401 Professional Drive
Gaithersburg, Maryland 20879

United States

Phone: 240-243-1201
Fax: 240-243-1018

Board Members Memberships*

Co-Founder, Chief Executive Officer, President and Director


Harvard Business School
Dartmouth College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$417,005

Stock Options*

Exercisable Options347,580
Unexercisable Options375,639
Total Number of Options723,219

Total Compensation*

Total Annual Cash Compensation$573,718
Total Short Term Compensation$417,005
Total Calculated Compensation$2,876,385
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLYC:US $7.05 USD -0.03


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLYCOMIMETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at